UBS O'Connor’s SOC Telemed, Inc. Class A Common Stock TLMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-750,000
Closed -$5.88M 1064
2020
Q4
$5.88M Buy
750,000
+75,393
+11% +$666K 0.12% 181
2020
Q3
$6.85M Sell
674,607
-940,393
-58% -$9.7M 0.17% 88
2020
Q2
$16.2M Sell
1,615,000
-85,000
-5% -$841K 0.36% 66
2020
Q1
$16.7M Buy
+1,700,000
New +$16.8M 0.34% 58

Other funds holding TLMD

UBS O'Connor's TLMD Position: Q1 2021 in Review

UBS O'Connor sold out of SOC Telemed, Inc. Class A Common Stock (TLMD) in Q1 2021, closing a stake of 750,000 shares — an estimated $5.88M sold.

UBS O'Connor first reported a position in TLMD in Q1 2020 and held it in 4 quarters. The position peaked at $16.7M in Q1 2020. 64 funds tracked by Wall St. Rank hold TLMD as of Q1 2021.

  • UBS O'Connor reported no remaining SOC Telemed, Inc. Class A Common Stock position as of Q1 2021 after selling out during the quarter.
  • UBS O'Connor sold 750,000 SOC Telemed, Inc. Class A Common Stock shares in Q1 2021, an estimated $5.88M.
  • UBS O'Connor first reported a position in SOC Telemed, Inc. Class A Common Stock in Q1 2020 and held it in 4 quarters.
  • UBS O'Connor's SOC Telemed, Inc. Class A Common Stock position peaked at $16.7M in Q1 2020.
  • 64 funds tracked by Wall St. Rank held SOC Telemed, Inc. Class A Common Stock as of Q1 2021.

Based on UBS O'Connor's 13F filing for Q1 2021, filed 14 May 2021.